Suppr超能文献

格列齐特在二元和三元体系中改善物理化学性质、生物活性和抗氧化活性。

Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity.

机构信息

Department of Biochemistry, Bahauddin Zakariya University, Multan 60800, Pakistan.

Department of Basic Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, Narowal 51600, Pakistan.

出版信息

Oxid Med Cell Longev. 2022 Nov 25;2022:2100092. doi: 10.1155/2022/2100092. eCollection 2022.

Abstract

The poor solubility of the antidiabetic drug gliclazide (Glc) is due to its hydrophobic nature. This research is aimed at improving Glc's solubility and drug release profile, as well as at investigating additional benefits such as bioactivity and antioxidant activity, by forming binary complexes with HPCD at different / ratios (1 : 1, 1 : 2.5, 1 : 4, and 1 : 9) and ternary complexes with HPCD and Tryp at 1 : 1 : 1, 1 : 1 : 0.27, 1 : 2.5 : 0.27, 1 : 3.6 : 3.6, 1 : 4 : 1, and 1 : 9 : 1, respectively. Complexes were prepared by the physical mixing (PM) and solvent evaporation (SE) methods. The prepared inclusion complexes were meticulously characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectra. To verify our findings, the inclusion complexes were evaluated by equilibrium solubility, drug release profile, kinetic models, and antidiabetic and antioxidant activities in animal models. Our results demonstrated that the solubility and drug release profile were found to be enhanced through binary as well as ternary complexes. Notably, ternary complexes with a ratio of 1 : 9 : 1 showed the highest solubility and drug release profile compared to all other preparations. Data on antioxidant activity indicated that the ternary complex had the higher total antioxidant status (TAS), superoxide dismutase (SOD), and catalase (CAT) activity than the binary complex and Glc alone, in contrast to the diabetic group. antidiabetic activity data revealed a high percentage reduction in the blood glucose level by ternary complexes (49-52%) compared to the binary complexes (45-46%; ≤ 0.05). HPCD and Tryp provide a new platform for overcoming the challenges associated with poorly soluble Glc by providing greater complexing and solubilizing capabilities and imparting ancillary benefits to improve the drug's antidiabetic and antioxidant activities.

摘要

抗糖尿病药物格列齐特(Glc)的溶解度差是由于其疏水性。本研究旨在通过与 HPCD 形成不同摩尔比(1:1、1:2.5、1:4 和 1:9)的二元复合物,以及与 HPCD 和 Tryp 形成 1:1:1、1:1:0.27、1:2.5:0.27、1:3.6:3.6、1:4:1 和 1:9:1 的三元复合物,来提高 Glc 的溶解度和药物释放特性,并研究其他益处,如生物活性和抗氧化活性。复合物通过物理混合(PM)和溶剂蒸发(SE)方法制备。通过 X 射线衍射(XRD)、扫描电子显微镜(SEM)和衰减全反射-傅里叶变换红外(ATR-FTIR)光谱对制备的包合物进行了详细的表征。为了验证我们的发现,通过平衡溶解度、药物释放特性、动力学模型以及动物模型中的抗糖尿病和抗氧化活性评估了包合物。我们的结果表明,通过二元和三元复合物都提高了溶解度和药物释放特性。值得注意的是,与所有其他制剂相比,摩尔比为 1:9:1 的三元复合物显示出最高的溶解度和药物释放特性。抗氧化活性数据表明,与二元复合物和 Glc 单独相比,三元复合物具有更高的总抗氧化状态(TAS)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性,而糖尿病组则相反。抗糖尿病活性数据表明,与二元复合物(45-46%; ≤ 0.05)相比,三元复合物可使血糖水平降低 49-52%。HPCD 和 Tryp 通过提供更大的络合和增溶能力,并赋予辅助益处来提高药物的抗糖尿病和抗氧化活性,为克服 Glc 溶解度差的挑战提供了一个新的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc6b/9718633/f627516e5a7b/OMCL2022-2100092.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验